ACE and hydrops fetalis: A recent systematic study that included a large number of patients with HF with reduced EF revealed that ARNI treatment was linked to an amelioration of the EF (+5.11%, 95% CI 4.06 to 6.16) and LV dimensions compared with patients who followed a treatment with angiotensin receptor blockers or angiotensin-converting enzyme suppressors [68].